# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 516 results.
Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.
Status: Not yet recruiting
Last Changed: Feb 05, 2020
First Received: Feb 12, 2019
Disease(s): Advanced Soft Tissue Sarcoma
Intervention(s): Standard arm: Trabectedin in monotherapy, Experimental arm: Trabectedin + Olaparib
Locations: Azienda Ospedaliero-Universitaria Di Bologna, Bologna, BO, Italy
Nuovo Ospedale di Prato, Prato, Firenze, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, MI, Italy
Istituto Clinico Humanitas, Rozzano, MI, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, Italy
... and 8 other locations.
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Status: Recruiting
Last Changed: Jul 22, 2019
First Received: Apr 26, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): Ascorbate
Locations: University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma
Status: Recruiting
Last Changed: Jun 21, 2019
First Received: Feb 13, 2017
Disease(s): Kaposi Sarcoma
Intervention(s): Smartphone confocal microscopy
Locations: Infectious Diseases Institute, Kampala, Uganda
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Jul 26, 2019
First Received: Oct 18, 2018
Disease(s): Sarcoma
Intervention(s): SHR-1210 Plus Apatinib, ADM Plus IFO or IFO Alone
Locations: Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, Shanghai, China
OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients
Status: Recruiting
Last Changed: Jan 03, 2019
First Received: Oct 05, 2018
Disease(s): Advanced Soft Tissue Sarcoma
Intervention(s): Olaratumab, Dexrazoxane, Doxorubicin
Locations: Helios Klinikum Bad Saarow, Bad Saarow, Germany
The PET- Retroperitoneal Sarcoma Study
Status: Not yet recruiting
Last Changed: Jan 13, 2020
First Received: Jan 13, 2020
Disease(s): Retroperitoneal Sarcoma
Intervention(s): PET MRI scan
Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas
Status: Not yet recruiting
Last Changed: Sep 21, 2018
First Received: Sep 21, 2018
Disease(s): Sarcoma, Soft Tissue
Intervention(s): Adaptive radiation therapy
Locations: Institut Paoli-Calmettes, Marseille, Bouches-du-Rhônes, France
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Dec 26, 2016
Disease(s): Sarcoma
Intervention(s): CBT-1®
Locations: Sarcoma Oncology Research Center, Santa Monica, California, United States
Mayo Clinic, Jacksonville, Florida, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
... and 2 other locations.
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Status: Not yet recruiting
Last Changed: Feb 05, 2020
First Received: Oct 31, 2019
Disease(s): Synovial Sarcoma
Intervention(s): Ramucirumab, Gemcitabine, Docetaxel
Locations: Mayo Clinic-Jacksonville, Jacksonville, Florida, United States
Washington University Medical School, Saint Louis, Missouri, United States
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
The Sydney Children's Hospitals Network, Westmead, New South Wales, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
... and 27 other locations.
Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan
Status: Recruiting
Last Changed: May 31, 2018
First Received: May 31, 2018
Disease(s): Ewing Sarcoma Family of Tumors
Intervention(s): MGMT methylation evaluation
Locations: Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Mi, Italy
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS, Candiolo, Turin, Italy
Orthopedic Rizzoli Institute, Bologna, Italy
Ospedale infantile Regina Margherita, Turin, Italy
The Royal Marsden NHS Foundation Trust, London, United Kingdom
... and 1 other locations.